Activities of Daily Living of Patients with Malignant Brain Tumors Assessed By Using Functional Independence Measurement Scoring SystemHiroshi Kanno1*, Jo Sasame1, Shigeta Miyake1, Satoshi Nakanowatari1, Atsuki Numata2, Nobuyo Nagatsuka2, Naomi Fukushige2, Taeko Ito2 and Yoshimitsu Inoue2
- Corresponding Author:
- Hiroshi Kanno
Department of Neurosurgery
Yokosuka City Hospital, Yokosuka, Japan
Tel: 81 46 856 3136
E-mail: [email protected]
Received Date: May 04, 2015; Accepted Date: June 13, 2015; Published Date: June 20, 2015
Citation: Kanno H, Sasame J, Miyake S, Nakanowatari S, Numata A, et al. (2015) Activities of Daily Living of Patients with Malignant Brain Tumors Assessed By Using Functional Independence Measurement Scoring System. Int J Neurorehabilitation 2:171.doi:10.4172/2376-0281.1000171
Copyright: © 2015 Kanno H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Patients with malignant brain tumors have varied degree of neurological impairments because of factors influencing activities of daily living (ADL). Those factors are related to characteristics of patients, tumor natures, and received treatment. However, factors influencing ADL of patients with malignant brain tumors are not fully elucidated. The functional independence measurement (FIM) is an ADL scoring system to determine impairment in different domains objectively. Here, we assessed ADL of 27 patients with malignant brain tumors at admission, discharge, 1 year and 2 years later using FIM scoring system, and identified factors influencing their ADL. In results, patient age and tumor pathology were identified as factors influencing ADL, while tumor site and operation type were not related to FIM scores. In conclusion, patient age and tumor pathology are identified as factors influencing ADL of patients with malignant brain tumors. Taking into account of those factors, neuro-rehabilitation program for patients with malignant brain tumors should be scheduled.